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A protective herd effect has been described after susceptible populations of children are
vaccinated with conjugate Haemophilus influenzae type b (Hib). Hib carriage was studied in
children aged 6–24 months attending day care centers in two cities in southern Brazil (Curitiba
and Porto Alegre). In Curitiba, routine immunization with Hib polyribosylribitol phosphate
polysaccharide–tetanus toxoid conjugate vaccine (PRP-T) in combination with diphtheria-
tetanus toxoids–pertussis vaccine (PRP-T/DTP) has been offered since September 1996; DTP
vaccine alone is routinely given in Porto Alegre. Children in Porto Alegre ( ) were 8n = 643
times less likely to have received adequate Hib vaccination and 4 times more likely to be Hib
carriers than children in Curitiba ( ; i.e., point prevalence of oropharyngeal coloniza-n = 647
tion, 4.8% vs. 1.2%). Point prevalence of carriage with non–type b or other nontypeable Hi
was similar in children of both cities. There was a vaccination effect on carriage rates in
children who received a primary 3-dose series, independent of the booster dose, suggesting
that a booster may be unnecessary to induce population protection.
Earlier studies showed that cases of Haemophilus influenzae
type b (Hib) invasive disease decrease sharply after Hib vac-
cination has been introduced into a susceptible population
[1–7]. Although some variation occurs between different vac-
cine formulations, conjugate vaccines against Hib protect
against invasive disease with an efficacy of 94%–100% [2, 5–7].
As a consequence, Hib disease has been nearly eliminated in
countries where widespread Hib conjugate vaccination has been
adopted [8]. In the United States, the incidence of Hib disease
among children began to drop after a polysaccharide–protein
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conjugate vaccine was introduced in 1988 for use among chil-
dren aged 18 months. Over the following years, many poly-
saccharide–protein conjugate vaccines became widely used, and
between 1987 and 1995 the incidence of invasive Hib disease
among US children aged !5 years declined by 96% (from 41
to 1.6 cases per 100,000 children) [4, 9]. A decrease in the cir-
culation of the pathogen appears to play an important role in
disease control. Moreover, unvaccinated children up to age 5
years showed oropharyngeal Hib carriage rates of 3%–6% [1,
10–12], whereas carriage rates among Hib conjugate vaccinees
were substantially lower (range, 0%–1.5%) [11–13].
In Brazil, Hib vaccination is not yet part of the national
immunization program, although some cities widely use Hib
vaccine. In Curitiba, the capital of the state of Parana, in mid-
September 1996, routine immunization was introduced with
lyophilized Hib vaccine consisting of purified polyribosylribitol
phosphate polysaccharide conjugated to tetanus toxoid, recon-
stituted with diphtheria–tetanus toxoids–pertussis vaccine in a
single syringe (PRP-T/DTP). Vaccine was given at ages 2, 4,
and 6 months, with a booster dose administered at age 15
months. One year after introduction of routine immunization
with PRP-T/DTP, the incidence of Hib meningitis among chil-
dren aged !5 years in Curitiba decreased from 35.4 (1996) to
9.7 (1997) cases per 100,000 [14].
 at Escola Paulista M
edicina on O
ctober 15, 2015
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
1154 Forleo-Neto et al. JID 1999;180 (October)
Table 1. Demographic characteristics of the cities studied for
Haemophilus influenzae type b (Hib) oropharyngeal colonization in
Brazilian children !5 years of age.
Demographic characteristic Curitiba Porto Alegre
Total population 1,400,000 1,300,000
Live births (1996) 25,000 24,000
Incidence of Hib meningitis
(cases/100,000) in children
!5 years old (1995)
27 21
Hib vaccine coverage rate in children !5 years old (%)
1996 !10 !10
1997 99 !10
In the present study, we compared the point prevalence of
oropharyngeal Hib colonization (i.e., carriage) among groups
of vaccinated and unvaccinated children who attended public
day care centers in two cities in southern Brazil, Curitiba and
Porto Alegre. The city of Porto Alegre follows national im-
munization recommendations set by the Ministry of Health,
based on the World Health Organization’s Expanded Pro-
gramme of Immunization for developing countries (i.e., im-
munization against bacille Calmette-Gue´rin at age 0–1 month;
hepatitis B at ages 0, 1, and 6 months; diphtheria-tetanus tox-
oids–pertussis [DTP] and oral poliovirus at ages 2, 4, and 6
months; and measles at age 9 months), plus measles-mumps-
rubella vaccine and booster doses of DTP and oral poliovirus
during the second year of life. Curitiba differs in that DTP
vaccine is replaced by a PRP-T/DTP combination. Curitiba
and Porto Alegre were chosen as investigation sites because of
their similar incidences of invasive Hib disease prior to Hib
vaccine implementation and because of the striking difference
in Hib vaccination coverage rates among children younger than
5 years of age (i.e., 99% in Curitiba and !10% in Porto Alegre).
In addition, the two cities have similar population demograph-
ics and weather conditions.
Materials and Methods
Enrollment. From October to December 1997 (during the Bra-
zil spring) and just 1 year after introduction of Hib vaccination in
Curitiba, boys and girls ages 6–24 months who attended municipal
day care centers in Curitiba and Porto Alegre were recruited (table
1), and specimens were collected. A typical day care center attended
by children in this study divided children into separate rooms ac-
cording to age, with <15 children in each room. Only children
living in a household with other children ages 3–10 years (hypo-
thetically being more prone to Hib exposure) were eligible for study
participation. Children were excluded from the study if they had
taken antibiotics up to 1 week before enrollment, were breast-feed-
ing and their mother had taken antibiotics up to 1 week before the
study, had a febrile illness, or did not fulfill any of the inclusion
criteria described above. Children who were exposed to antibiotics
were excluded because of contradictory data in the literature re-
garding the influence of antibiotic use on Hib oropharyngeal car-
riage. Children with febrile illnesses were excluded mainly to avoid
the possible temporal association between events attributable to
the ongoing disease and the specimen collection, which could cause
the parents some degree of distress and suspicion regarding the
safety of the procedure.
Children !1 year of age were considered adequately immunized
against Hib if, prior to the study, they had received 3 doses of
vaccine (when immunization began before age 6 months) or 2 doses
(when immunization began between 7 and 12 months of age). For
those vaccinated after age 12 months, a single injection was con-
sidered satisfactory. These definitions were used for data entry and
statistical analysis.
Because routine Hib vaccination was introduced in Curitiba in
mid-September 1996, 1 year before the study began (October 1997),
these groups of children were likely to have received the following
number of Hib vaccine doses: children aged 6 months (born in
April 1997), 2 or 3 doses of the primary series; aged 7–14 months
(born between August 1996 and March 1997), 3 doses; aged 15–18
months (born between April and July 1996), 1 or 2 doses of the
primary series plus a booster dose when they reached the appro-
priate age; and aged 19–24 months (born between October 1995
and March 1996), a single booster dose at age 15 months (Hib
vaccination was introduced after they were 6 months old). A small
proportion of the children aged 15–24 months, who may have had
access to immunization through private practitioners prior to pub-
lic introduction of Hib vaccine, may have received up to 4 doses.
Likewise, a small proportion of children enrolled in Porto Alegre
received from 1 to 4 doses of vaccine, depending on their age, in
private immunization clinics (the only access to Hib vaccination
in that city).
Specimen collection. Prior to study initiation, 2 public health
nurses from each city were trained to take oropharyngeal swabs.
During the 8-week enrollment/collection phase, the local pair of
nurses responsible for specimen collection was always assisted by
1 nurse from the other city, to avoid sampling bias. After swab
sampling, the material was immediately placed in Stuart transport
medium and given a coded identification number. On the same day,
samples were sent by air to a reference microbiology laboratory at
the Santa Casa de Miserico´rdia de Sa˜o Paulo Hospital. The max-
imum time that elapsed between collection and inoculation on Hib-
specific culture medium was 24 h.
Microbiology. At the microbiology laboratory, the swabs were
inoculated onto selective media: 10% horse blood–chocolate brain-
heart infusion agar plate (Difco Laboratories, Detroit) supple-
mented with 300 mg/L bacitracin [15]. Up to 5 suspected colonies
per plate were studied. The isolates were identified through Gram’s
staining, recognition of typical morphology on chocolate agar
plates, a requirement of NAD for growth by satellite phenomenon
on ordinary blood agar, and by inability to convert g-aminole-
vulinic acid (Sigma, St. Louis) to porphyrins. Fermentation of glu-
cose, sucrose, lactose, xylose, and mannose in phenol red broth
base (Difco) were performed for species identification [15, 16]. Cap-
sular serotyping was done by slide agglutination with antisera to
H. influenzae types a–f (Difco).
Statistics. A standard form containing data regarding birth
date, sex, ethnicity, number of siblings at home, number of class-
mates, number of rooms in the household, Hib vaccination status
(based on immunization records), and other relevant information
was completed by a study nurse for each study participant. An
expected sample size of 643 subjects per study group was calculated
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Table 2. Characteristics of the study population of children from two
cities in southern Brazil according to age, sex, ethnicity, number of
other children per class at the day care, and number of rooms at home.
Characteristic
Curitiba
(n = 647)
Porto Alegre
(n = 643)
Age (days), median (range) 498 (180–745) 515 (182–749
Sex
Male 314 (48.5) 356 (55.4)
Female 333 (51.5) 284 (44.6)
Ethnicitya
White 522 (80.7) 422 (65.6)
Other 125 (19.3) 221 (34.4)
Previous Hib vaccinationa
Adequate or partially
adequateb
606 (93.7) 71 (11.0)
No. of children/class at day
care center, median
(range)
15 (10–26) 17 (3–50)
No. of rooms at homec
!5 262 (40.5) 226 (37.0)
>5 385 (59.5) 385 (63.0)
NOTE. Data are no. (%) unless otherwise indicated.
a .P ! .01
b Adequate vaccination: children aged !1 year, 3 doses when immunization
began before age 6 months or 2 doses when immunization began between age 7
and 12 months; children aged 11 year, single dose. Partially adequate vaccination:
children aged !1 year, no more than 2 doses when immunization began before
age 6 months or no more than 1 dose when immunization began between age 7
and 12 months.
c Thirty-two children from Porto Alegre who lived in a foster care facility are
not included in this item analysis.
Table 3. Frequency distribution of capsulated Haemophilus influen-
zae isolated from oropharyngeal swabs in children from day care
centers in two cities, Curitiba and Porto Alegra, in southern Brazil,
with high and low vaccination coverage, respectively.
Haemophilus serotype
Curitiba
(n = 647; high coverage)
Porto Alegre
(n = 643; low coverage)
a 1 (0.15) 2 (0.31)
ba 8 (1.2) 31 (4.8)
c 2 (0.31) 1 (0.16)
f 4 (0.62) 4 (0.62)
Nontypeable 91 (14.1) 76 (11.8)
NOTE. Data are no. (%).
a .P ! .01
assuming , , and a 4% difference in Hib carriage ratesP = .8 a = .05
between vaccinated and unvaccinated subjects. Oropharyngeal Hib
carriage rates were compared between study groups by use of odds
ratios (ORs) and x2 or Fisher’s exact test. A subgroup of 32 children
from a Porto Alegre foster care facility was excluded from the
analysis of the number of siblings aged !8 years, number of rooms
at home, and number of classmates.
Results
About 94% of the children enrolled in Curitiba had been
previously vaccinated against Hib (i.e., adequately or partially
immunized for their age), an 8-fold greater vaccination rate
than in Porto Alegre (11%; ). Oropharyngeal swabs wereP ! .01
obtained from 1290 children (647 in Curitiba, 643 in Porto
Alegre). Characteristics of the study population are described
in table 2. In brief, there was no statistically significant differ-
ence between the children in the two cities in terms of median
age, sex, number of classmates, or number of rooms at home.
There was a significant difference in ethnicity distribution
( ), as there were 23% more white children among theP ! .01
subjects in Curitiba. According to data available from both
municipalities, 10.1% and 7.5% of children attended public day
care centers in Curitiba and Porto Alegre, respectively (E. M.
C. P. Maluf and A. K. Pustai, personal communication).
Overall, the prevalence of Hib carriage was 3.0%. It was
significantly greater among children in the low coverage city
(Porto Alegre, 4.8%) than in the high coverage city (Curitiba,
1.2%; ). The carriage prevalence of other capsulatedP ! .01
(e.g., types a, c, and f) and nontypeable H. influenzae was sim-
ilar among children in both cities (table 3). Relationships be-
tween the study variables and Hib carriage rates are shown in
table 4. When children in both cities were considered together,
adequately immunized children were 4 times less likely to be
Hib carriers than partially vaccinated or unvaccinated children
(1.2% [7/607] vs. 4.7% [32/683], respectively; ). AmongP ! .001
subjects in the low coverage city, carriage prevalence among
partially vaccinated or unvaccinated children was 5.3% (31/
583); in contrast, there were no carriers among adequately im-
munized subjects (0/60). A similar phenomenon was not ob-
served with children from the high coverage city: prevalence of
1.0% (1/100) among partially vaccinated or unvaccinated chil-
dren versus 1.3% (7/547) among adequately immunized sub-
jects. Point prevalence Hib carriage rates among adequately
immunized children in the two cities were not significantly dif-
ferent (Fisher’s exact test, ).P 1 .999
When subgroups in the low coverage city were compared,
there was an increased risk for Hib carriage (OR, 2.25; P !
) in children with >1 sibling aged !8 years: 3.2% (11/348).05
for no siblings versus 6.8% (18/263) for >1 sibling. However,
among children in the high vaccine coverage city, the number
of siblings had no influence on the carriage rates: 1.4% (4/295)
for no siblings versus 1.1% (4/352) for >1 sibling.
Discussion
A recent review of the epidemiology of Hib disease in Latin
America and the Caribbean estimated that the overall incidence
of Hib meningitis among children aged 0–4 years is 35 cases
per 100,000 children [17]. Large-scale Hib vaccination programs
are rare in this region, and their effect has not yet been eval-
uated sufficiently. Nevertheless, data from Chile [6] and Uru-
guay [18] show that the inclusion of conjugate Hib vaccine in
immunization programs in South American countries can be
as effective as in the programs implemented in North America
and Europe.
Reducing transmission may play an important role in Hib
disease control. Unlike immunization with plain polysaccharide
Hib vaccine (PRP), which does not affect carriage rates [1], the
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Table 4. Haemophilus influenzae type b (Hib) carriage distribution according to previous Hib vaccination,
number of siblings !8 years old, number of rooms in the household, and number of classmates at the day
care center in two southern Brazil cities, Curitiba and Porto Alegre, with high and low Hib vaccination
coverage.
Characteristic
Curitiba
(high coverage)
Porto Alegre
(low coverage) Both cities
Hib positive (%) Total Hib positive (%) Total Hib positive (%) Total
Vaccination status
Adequately immunized for age 7 (1.3) 547 0 60 7 (1.2) 607
Partially immunized for age 1 (1.7) 59 1 (9.1) 11 2 (2.9) 70
Unvaccinated 0 41 30 (5.2) 572 30 (4.9) 613
Siblings !8 years olda
None 4 (1.4) 295 11 (3.2) 348 15 (2.3) 643
11 4 (1.1) 352 18 (6.8) 263 22 (3.6) 615
Rooms at homea
15 4 (1.5) 262 11 (4.9) 226 15 (3.1) 488
!5 4 (1.0) 385 18 (4.7) 385 22 (2.8) 774
Classmates in day carea
!15 3 (1.5) 194 19 (4.9) 391 22 (3.8) 585
115 5 (1.1) 453 10 (4.5) 220 15 (2.2) 673
a Not included in analysis, 32 children from Porto Alegre who lived in a foster care facility.
use of conjugate vaccines is associated with a decrease in prev-
alence of Hib carriage among vaccinees [11–13, 19, 20], which
will reduce transmission to and exposure of nonimmune per-
sons [21].
In this point prevalence study in two cities in southern Brazil,
rates of oropharyngeal Hib carriage correlated inversely with
Hib vaccine coverage levels. Children from Porto Alegre, who
were 8 times less likely to have received adequate Hib vacci-
nation, were 4 times more likely to be Hib carriers (4.8%) than
children from Curitiba (1.2%). Although the children in both
cities lived under similar geographic, climatic, and socioeco-
nomic conditions and shared most demographic characteristics,
there was a significant difference in ethnicity. Although some
reports suggest that ethnic differences reflect socioeconomic risk
factors [22], the subjects in our study all attended public day
care centers, suggesting that their families were nearly exclu-
sively low income.
It is possible that the methods used for Hib isolation in our
study slightly underestimated Hib oropharyngeal carriage rates,
either by decreasing the yield by not using antiserum agar or
by overgrowth of gram-negative organisms consequent to the
delayed inoculation. Nevertheless, there is no reason to believe
that this limitation would invalidate the comparison of Hib
carriage rates between the two cities in the study.
Although the point prevalence in adequately vaccinated chil-
dren from Curitiba and Porto Alegre did not differ significantly,
evidence for herd protection was found only among the subjects
in Curitiba, where high Hib vaccination coverage was achieved.
When only children from Porto Alegre were considered (where
just 9.3% [60/643] were adequately immunized against Hib),
there was a clear-cut difference in carriage between adequately
immunized (0% carriage rate [0/60]) and partially vaccinated/
unvaccinated subjects (5.6% carriage rate [31/583]). Lower car-
riage rates, when compared with those of children in Porto
Alegre, were observed among all Curitiba subgroups (see table
4), suggesting that the protective effect extended to all subjects,
regardless of vaccination status. Published studies suggest that
unvaccinated children who have little exposure to Hib are un-
likely to be Hib carriers. For example, the Hib carriage rate
tends to be lower among unvaccinated siblings of vaccinees
than in other unvaccinated persons [11]. The data from Porto
Alegre coincide with the results of H. influenzae carriage studies
in both the Dominican Republic and Costa Rica, which eval-
uated children belonging to roughly the same age group, dem-
onstrating an association between increased carriage and the
presence of another child in the household [23, 24].
While our results seem to indicate a clear effect of Hib vac-
cination on carriage rates in nonvaccinated children in a high
coverage situation, the actual effect on infection rates is not
necessarily so clear-cut. Two good examples come from data
collected in The Netherlands [25] and Alaska [26]. In The Neth-
erlands, children born before the start of nationwide vaccina-
tion (April 1993) did not receive Hib vaccination. Although the
incidence of Hib cases decreased sharply among vaccinated
children during the following 3 years, the number of expected
cases in unvaccinated children did not decrease. In Alaska, the
incidence of invasive Hib disease decreased dramatically after
the introduction of vaccination with Hib conjugate vaccine po-
lyribosylribitol phosphate Neisseria meningitidis outer
membrane protein vaccine. However, when the vaccination reg-
imen was changed to diphtheria-tetanus toxoids–whole cell per-
tussis vaccine conjugated with Hib oligosaccharide CRM197
(DPT-HbOC), which is apparently less protective after the first
dose to the youngest children, the number of Hib invasive cases
increased, suggesting ongoing carriage and transmission in the
population. Carriage rates among this population were
2.2%–13.2% (mean, 9.3%), and higher rates were associated
with overcrowding and increasing age. Both studies suggest that
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elimination of Hib circulation might not be achieved if the
vaccination schemes adopted do not have a direct and age-
extended effect on carriage rates.
Although the subgroup of 32 foster care residents from Porto
Alegre had a particularly high Hib carriage point prevalence
(6.3%), they were not excluded from the comparisons of Hib
carriage point prevalence between children from Porto Alegre
and Curitiba or between adequately immunized and partially
vaccinated or unvaccinated children. They were excluded from
calculations related to living conditions, where they did not fit
in a specific category (e.g., siblings !8 years old, number of
rooms in the household). Even if these subjects had been ex-
cluded from the other calculations, the 2 additional Hib carriers
in this subset would not have changed the significant differences
seen between the Hib carriage point prevalence in Curitiba and
Porto Alegre and between adequately immunized and partially
vaccinated or unvaccinated children (data not shown).
Carriage rates for other typeable H. influenzae did not differ
between children from Curitiba and from Porto Alegre, show-
ing the specificity of Hib vaccination. This observation is in
accordance with other reports that demonstrated that intro-
duction of large-scale Hib vaccination does not result in the
increase of non–type b or other nontypeable H. influenzae dis-
eases, as was feared would happen if the niche occupied by Hib
colonization in the oropharynx was replaced by similar path-
ogens [9, 27]. Another important consideration is that the effect
of vaccination on carriage rates observed in this study occurred
in a population that had received either a primary 3-dose series
without a booster (children aged !1 year) or a single dose of
Hib vaccine (children in the second year of life). This could
encourage administrators of vaccination programs in devel-
oping countries, where financial resources are scarce, to apply
schedules that do not depend on a booster dose.
In summary, this study shows that widespread immunization
with a Hib conjugate vaccine is associated with significant re-
duction in the number of Hib oropharyngeal carriers among
Hib-immunized children. In a population receiving wide cov-
erage with a Hib conjugate vaccine, the decrease in Hib carriage
also was extended to nonimmunized children. In addition, our
data provide support for the concept that it may be possible
to achieve a population-protective effect with only a primary
immunization schedule with Hib conjugate vaccine, without a
booster dose. The protection of individuals provided by sat-
isfactory and persistent anti-Hib polysaccharide antibody con-
centrations leads to lower rates of carriage, which is a protective
mechanism for populations because of diminished Hib circu-
lation and lower rates of transmission.
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